Technical note: The calculated real world BNT162b2 vaccine efficacy was 88% when accounting for asymptomatic cases

COVID-19 trials have relied on symptomatic subjects for judging the effectiveness of vaccine candidates, whereas asy-mptomatic subjects have been suspected as the main driver of the pandemic. An assumption of the same impact on symptomatic and asymptomatic breakthrough infections is shown to be flaw...

Full description

Saved in:
Bibliographic Details
Main Author: Richard Paul Junghans (Author)
Format: Book
Published: Taylor & Francis Group, 2021-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available